Archive for January, 2019

To sleep, perchance to heal: Newly discovered gene governs need for slumber when sick

Humans spend nearly one-third of their lives in slumber, yet sleep is still one of biology’s most enduring mysteries. Little is known about what genetic or molecular forces drive the need to sleep — until now. In a study of over 12,000 lines of fruit flies, researchers have found a single gene, called nemuri, that […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →

Exercise benefits brains, changes blood flow in older adults, study finds

Exercise training alters brain blood flow and improves cognitive performance in older adults, though not in the way you might think. A new study showed that exercise was associated with improved brain function in a group of adults diagnosed with mild cognitive impairment (MCI) and a decrease in the blood flow in key brain regions. […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →

How the immune system protects us against bowel cancer

Researchers have discovered a protective mechanism which is used by the body to protect intestinal stem cells from turning cancerous. The body’s innate immune system was found to play a pivotal role in this regard. The researchers were able to demonstrate that, rather than having a purely defensive role, the immune system is crucial in […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →

Method to 'turn off' mutated melanoma

Melanoma is the deadliest form of skin cancer and notorious for its resistance to conventional chemotherapy. Approximately 25 percent of melanoma is driven by oncogenic mutations in the NRAS gene, making it a very attractive therapeutic target. However, despite decades of research, no effective therapies targeting NRAS have been forthcoming. Source: Method to 'turn off' […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →

Method to 'turn off' mutated melanoma

Melanoma is the deadliest form of skin cancer and notorious for its resistance to conventional chemotherapy. Approximately 25 percent of melanoma is driven by oncogenic mutations in the NRAS gene, making it a very attractive therapeutic target. However, despite decades of research, no effective therapies targeting NRAS have been forthcoming. Source: Method to 'turn off' […]

Continue Reading →

Posted in: AICHC News

Leave a Comment (0) →
Page 1 of 3 123